MUMBAI Feb 8 Indian drugmaker Cipla Ltd
reported a 43.7 percent jump in third-quarter net
profit, beating analysts' expectations.
Net profit for the October-December quarter rose to 3.75
billion rupees ($55.79 million) from 2.61 billion a year
That beat the 3.70 billion rupees forecast by 23 analysts on
average, data from Thomson Reuters I/B/E/S showed.
India's fifth-largest drugmaker by sales derives most of its
revenue from its home market, but is building its presence in
markets such as the United States and the UK, where during the
third quarter it launched the Seroflo inhaler, used for the
treatment of asthma.
($1 = 67.2150 Indian rupees)
(Reporting by Zeba Siddiqui; editing by Swati Bhat and Jason